Matches in Nanopublications for { ?s ?p "[These studies provide the first direct proof that bicistronic siRNA construct for uPAR and cathepsin B (pUC) reduces Y925-FAK activity and this inhibition is rescued by overexpression of both uPAR and cathepsin B which clearly demonstrates that pUC could thus be a potential therapeutic approach as an anti-angiogenic agent in meningioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_assertion description "[These studies provide the first direct proof that bicistronic siRNA construct for uPAR and cathepsin B (pUC) reduces Y925-FAK activity and this inhibition is rescued by overexpression of both uPAR and cathepsin B which clearly demonstrates that pUC could thus be a potential therapeutic approach as an anti-angiogenic agent in meningioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance.